Back
iShares BB Rated Corporate Bond ETF Vs. Regeneron Pharmaceuticals, Inc. Industry Stock Comparison
Sell
29
HYBB
iShares BB Rated Corporate Bond ETF
Last Price:
$47.17
Seasonality Move:
-1.76%
Buy
59
REGN
Regeneron Pharmaceuticals, Inc.
Last Price:
$772.98
Seasonality Move:
12.13%
Sell
29
iShares BB Rated Corporate Bond ETF (HYBB)
is a Sell
Is iShares BB Rated Corporate Bond ETF a Buy, Sell or Hold?
-
The current iShares BB Rated Corporate Bond ETF [HYBB] share price is $47.03. The Score for HYBB is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
HYBB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Regeneron Pharmaceuticals, Inc. (REGN)
is a Buy
Is Regeneron Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Regeneron Pharmaceuticals, Inc. [REGN] share price is $780.50. The Score for REGN is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
REGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HYBB Stock Price Chart
What is iShares BB Rated Corporate Bond ETF's stock price today?
-
The iShares BB Rated Corporate Bond ETF share price today is $47.03Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HYBB is experiencing selling pressure, which indicates risk of future bearish movement.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals, Inc.'s stock price today?
-
The Regeneron Pharmaceuticals, Inc. share price today is $780.50Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing slight buying pressure.
HYBB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 47.46 | Sell |
| Chaikin Money Flow: | -27531 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47 - 47.2) | Sell |
| Bollinger Bands (100): | (46.91 - 47.25) | Sell |
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 216.48 | Buy |
| Relative Strength Index (14 RSI): | 65.27 | Buy |
| Chaikin Money Flow: | 70647 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (725.9 - 779.36) | Buy |
| Bollinger Bands (100): | (557.81 - 715.59) | Buy |
HYBB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.06 | Sell |
| 20-day SMA: | 47.1 | Sell |
| 50-day SMA: | 47.09 | Sell |
| 200-day SMA: | 46.66 | Buy |
| 8-day EMA: | 47.07 | Sell |
| 20-day EMA: | 47.08 | Sell |
| 50-day EMA: | 47.08 | Sell |
| 200-day EMA: | 46.81 | Buy |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 772.52 | Buy |
| 20-day SMA: | 747.31 | Buy |
| 50-day SMA: | 699.49 | Buy |
| 200-day SMA: | 602.77 | Buy |
| 8-day EMA: | 674.04 | Buy |
| 20-day EMA: | 427.09 | Buy |
| 50-day EMA: | 211.88 | Buy |
| 200-day EMA: | 59.42 | Buy |
iShares BB Rated Corporate Bond ETF Earnings Growth & HYBB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Regeneron Pharmaceuticals, Inc. Earnings Growth & REGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $3.81 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.74 per share, and an increase next year of $1.14 per share.
iShares BB Rated Corporate Bond ETF Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regeneron Pharmaceuticals, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||